A Research on the KangLaiTe Lnjection in Treating the Liver Metastasis

HUANG Ting,CHEN Zhen,YANG Xue-fei,LI Yong,ZHANG Zhi-di,HUANG Ling,ZHANG Jian-gang,ZHANG Xiao-li
DOI: https://doi.org/10.13193/j.archtcm.2009.03.62.huangt.081
2009-01-01
Abstract:Objective:To observe the inhibiting effect of the KangLaiTe Injection(KLT)and hepatic arterial ligation on rat's spleen transplantation tumor and the Liver Metastasis,and to text the inhibiting effect of this two methods on the expressions of the matrix metalloproteinase(MMP-1)and the hepatocyte growth factor(HGF)in rats' metastatic hepatoma.Methods:W256 carcinosarcoma cells were injected into lower part of Wistar rats' spleen to set up a liver metastasis model,all rats were randomly divided into four groups:KLT group,KLT plus ligation group,ligation group and control group.Calculate the inhibition ratios of the spleen tumor's weight and the liver metastasis,use the in-situ hybridization method to observe the mRNA expressions of the MMP-1 and the HGF in the tumor cell.Results:Both the KLT group and the KLT plus ligation group can conspicuously inhibit the weight of spleen transplantation tumor and the mRNA expression of the MMP-1 in rats' metastatic hepatoma;The KLT group can also inhibit the formation rate of the liver metastasis;each group had a lower mRNA expression of the HGF contrast with the control group.Conclusion:The KLT injection can inhibit both growth velocity of the spleen transplantation tumor and the liver Metastasis,lowing down the expression of the MMP-1 could be an important suppressive mechanism of this drug.There is also a decreased expression of the MMP-1 in the KLT plus ligation group which indicated that the two methods combination should be optimized to get a satisfactory curative effect.
What problem does this paper attempt to address?